Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: arnie h who wrote (758)	5/7/1998 10:40:00 AM
From: yosi s	Read Replies (1) \| Respond to of 1491

Arnie I agree with you on your post. and I am sure that Omer will not argue against it either,as I gather from his post, ( though I am sure that Omer can speak for himself.) The point is that NOW after Lotemax and Alrex being REAL product and not a promise PARS is in another ball park. it is a new type of biotech, one with a revenue stream. as such it will have less need to raise money and if needed a lot easier, with much better terms, And that is great for it share holders. When I spoke with PARS, CFO, this was his opinion as well, my interpretation.. Again I share the euphoria of Entremed. But today Some of those that were quoted, in NYTimes are saying they were taken out of contex. ( My limited experience with media news is that what ever get to the printed page sometimes is far from what was said. Especially when one talks scientific jargon and the other not. )